The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review

Irina V. Poddubnaya; Joseph Gligorov; Liudmila G. Zhukova; Elena I. Kovalenko; M. A. Frolova

doi:10.26442/18151434.2020.4.200568

Современная онкология (Feb 2021)

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review

Irina V. Poddubnaya,
Joseph Gligorov,
Liudmila G. Zhukova,
Elena I. Kovalenko,
M. A. Frolova

Affiliations

Irina V. Poddubnaya: ORCiD; Russian Medical Academy of Continuous Professional Education
Joseph Gligorov: Sorbonne University
Liudmila G. Zhukova: A.S.Loginov Moscow Clinical Scientific Practical Center of the Department of Health of Moscow
Elena I. Kovalenko: ORCiD; Blokhin National Medical Research Center of Oncology
M. A. Frolova: N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

DOI: https://doi.org/10.26442/18151434.2020.4.200568
Journal volume & issue: Vol. 22, no. 4
pp. 47 – 55

Abstract

Read online

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer was held on 16th October 2020. The French and Russian oncology experts shared information and exchanged experience concerning the application of the first PI3K inhibitor alpelisib.

Published in Современная онкология

ISSN: 1815-1434 (Print); 1815-1442 (Online)
Publisher: IP Habib O.N.
Country of publisher: Russian Federation
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://modernonco.orscience.ru/

About the journal

Abstract

Keywords